1-5 of 5
Ronald M. Sobecks
Close
Sort by
Journal Articles

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

Clinical Trials & Observations
Vikas Gupta, James A. Kennedy, Jose-Mario Capo-Chichi, Soyoung Kim, Zhen-Huan Hu, Edwin P. Alyea, Uday R. Popat, Ronald M. Sobecks, Bart L. Scott, Aaron T. Gerds, Rachel B. Salit, H. Joachim Deeg, Ryotara Nakamura, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5562–5573.
https://doi.org/10.1182/bloodadvances.2020002727
Published: 2020
Includes: Supplemental data
Journal Articles

Comparison of outcomes of HCT in blast phase of BCR-ABL1 − MPN with de novo AML and with AML following MDS

Vikas Gupta, Soyoung Kim, Zhen-Huan Hu, Ying Liu, Mahmoud Aljurf, Ulrike Bacher, Amer Beitinjaneh, Jean-Yves Cahn, Jan Cerny, Edward Copelan, Shahinaz M. Gadalla, Robert Peter Gale, Siddhartha Ganguly, Biju George, Aaron T. Gerds, Usama Gergis, Betty K. Hamilton, Shahrukh Hashmi, Gerhard C. Hildebrandt, Rammurti T. Kamble, Tamila Kindwall-Keller, Hillard M. Lazarus, Jane L. Liesveld, Mark Litzow, Richard T. Maziarz, Taiga Nishihori, Richard F. Olsson, David Rizzieri, Bipin N. Savani, Sachiko Seo, Melhem Solh, Jeff Szer, Leo F. Verdonck, Baldeep Wirk, Ann Woolfrey, Jean A. Yared, Edwin P. Alyea, Uday R. Popat, Ronald M. Sobecks, Bart L. Scott, Ryotaro Nakamura, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4748–4757.
https://doi.org/10.1182/bloodadvances.2020002621
Published: 2020
Includes: Supplemental data
Journal Articles

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation

Clinical Trials & Observations
Daniel Weisdorf, Sarah Cooley, Tao Wang, Elizabeth Trachtenberg, Cynthia Vierra-Green, Stephen Spellman, Jennifer A. Sees, Ashley Spahn, Jenny Vogel, Todd A. Fehniger, Ann E. Woolfrey, Steven M. Devine, Maureen Ross, Edmund K. Waller, Ronald M. Sobecks, Joseph McGuirk, Betul Oran, Sherif S. Farag, Tsiporah Shore, Koen Van Besien, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2020) 4 (4): 740–754.
https://doi.org/10.1182/bloodadvances.2019001053
Published: 2020
Includes: Supplemental data
Journal Articles

Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

Betty K. Hamilton, Lisa A. Rybicki, David Grove, Christina Ferraro, Jamie Starn, Brittany Hodgeman, Jamie Elberson, Victoria Winslow, Donna Corrigan, Aaron T. Gerds, Rabi Hanna, Matt E. Kalaycio, Ronald M. Sobecks, Navneet S. Majhail, Raed A. Dweik
Journal: Blood Advances
Blood Adv (2019) 3 (18): 2732–2737.
https://doi.org/10.1182/bloodadvances.2019000345
Published: 2019
Journal Articles

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, Sandeep Jain, Amer Assal, Jan Cerny, Edward A. Copelan, Andrew Daly, Zachariah DeFilipp, Shahinaz M. Gadalla, Robert Peter Gale, Siddhartha Ganguly, Betty K. Hamilton, Gerhard Carl Hildebrandt, Jack W. Hsu, Yoshihiro Inamoto, Abraham S. Kanate, H. Jean Khoury, Hillard M. Lazarus, Mark R. Litzow, Sunita Nathan, Richard F. Olsson, Attaphol Pawarode, Olle Ringden, Jacob M. Rowe, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sachiko Seo, Nirav N. Shah, Melhem Solh, Robert K. Stuart, Celalettin Ustun, Ann E. Woolfrey, Jean A. Yared, Edwin P. Alyea, Matt E. Kalaycio, Uday Popat, Ronald M. Sobecks, Wael Saber
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2922–2936.
https://doi.org/10.1182/bloodadvances.2018024844
Published: 2018
Includes: Supplemental data